Voyager Therapeutics, Inc.
VYGR
$3.26
-$0.15-4.27%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 116.34M | 141.48M | 196.45M | 208.93M | 215.59M |
| Total Receivables | 3.15M | 1.65M | 2.92M | 4.04M | 2.53M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.74M | 3.86M | 325.00K | 6.62M | 9.77M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | 3.00M | -- | -- |
| Total Current Assets | 125.23M | 146.98M | 202.69M | 219.59M | 227.89M |
|
|
|||||
| Total Current Assets | 125.23M | 146.98M | 202.69M | 219.59M | 227.89M |
| Net Property, Plant & Equipment | 37.10M | 39.43M | 41.61M | 43.03M | 44.89M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.95M | 2.74M | 2.74M | 5.61M | 2.87M |
| Total Assets | 197.75M | 219.33M | 252.28M | 288.31M | 322.10M |
|
|
|||||
| Total Accounts Payable | 1.61M | 2.72M | 5.01M | 2.12M | 1.80M |
| Total Accrued Expenses | 7.95M | 6.97M | 12.10M | 14.95M | 12.03M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.88M | 7.36M | 7.84M | 7.85M | 7.64M |
| Total Finance Division Other Current Liabilities | 244.00K | 395.00K | 1.59M | 10.58M | 20.52M |
| Total Other Current Liabilities | 244.00K | 395.00K | 1.59M | 10.58M | 20.52M |
| Total Current Liabilities | 16.69M | 17.45M | 26.54M | 35.50M | 41.98M |
|
|
|||||
| Total Current Liabilities | 16.69M | 17.45M | 26.54M | 35.50M | 41.98M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 25.69M | 27.20M | 28.66M | 30.52M | 32.57M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.00M | 1.00M | 1.00M | 2.47M | 3.61M |
| Total Liabilities | 43.38M | 45.66M | 56.20M | 68.49M | 78.16M |
|
|
|||||
| Common Stock & APIC | 653.11M | 647.77M | 641.95M | 638.30M | 634.75M |
| Retained Earnings | -498.32M | -473.84M | -445.91M | -418.48M | -390.59M |
| Treasury Stock & Other | -421.00K | -263.00K | 32.00K | 7.00K | -221.00K |
| Total Common Equity | 154.38M | 173.67M | 196.08M | 219.83M | 243.94M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 154.38M | 173.67M | 196.08M | 219.83M | 243.94M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 154.38M | 173.67M | 196.08M | 219.83M | 243.94M |
|
|
|||||